ACNP is a non-profit, professional society dedicated to advancing the scientific understanding of and facilitating communication about disorders of the brain and behavior in order to advance their prevention and treatment.
Clinical trials in psychiatry rely on measures of symptomatology, not biology.
This @ACNPorg position paper lays out why validated biomarkers in psychiatry have lagged behind fields like Alzheimer's and ALS, and what it will take to close the gap: precompetitive data sharing,
ACNP and Neuropsychopharmacology are proud to announce our new partnership with Elsevier starting January 2027 - Click Here to Read More ➡️ https://tinyurl.com/zdrwxa23
ABC Congressional Neuroscience Caucus Briefing: Psychedelics in Brain Health - Keynote: Jaclyn “Jax” Scott, - Moderator: Mark M. Rasenick, PhD, Panel of Experts: Tiffany Farchione, MD, FAPA, Harriet de Wit, PhD, Ivan Montoya, MD, MPH, Daniel Karlin, MD, MA, Steve Levine, MD 🧠